Search results
1 in 8 U.S. Adults Have Taken Ozempic or Similar Drugs, According to a New Survey
People via Yahoo News· 2 days agoMost adults (62%) say they have taken a GLP-1 drug to treat a chronic condition including diabetes...
Aging Matters: Virtual AgingWell Series planned for Tuesday
Winston-Salem Journal· 1 day agoThe AgingWell Series will be presented from 5:30 to 6:30 p.m. Tuesday via Zoom. The series is...
1 in 8 U.S. Adults Have Taken Ozempic or Similar Drugs, According to a New Survey
People Magazine· 2 days agoAs GLP-1 medications continue to make headlines as an increasingly popular tool for weight loss, a...
A year after the end of the COVID-19 emergency, Oregon among top states keeping people covered
The World· 6 days agoThis ended when the pandemic emergency ended, so over the last year Oregon has been making sure...
LifeMD, Inc. (NASDAQ:LFMD) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoLifeMD, Inc. (NASDAQ:LFMD) Q1 2024 Earnings Call Transcript May 8, 2024 LifeMD, Inc. isn’t one of...
Social Security Changes Projected Date For When Benefits Would Need To Be Cut
Disability Scoop· 3 days agoImproved performance by the U.S. economy has prompted the federal government to push back its...
Where did all the medical appointments go?
Newsday· 4 days agoPatients who were new to a medical practice waited an average of 26 days nationwide to see a physician in 2022, up from about 24 days in 2017 and 21 days...
One in eight U.S. adults have taken Ozempic or similar weight loss drugs
Dallas Morning News· 3 days agoOne in eight US adults has tried medications from the fast-growing class of new diabetes and obesity...
Tampa Bay Times: Retirement is a growing luxury in the US
Bristol Herald Courier· 5 days agoOlder adults add incredible value to America’s workforce. A survey released last month by AARP puts...
Maximus Inc (MMS) Surpasses Analyst Revenue Forecasts with Stron
Guru Focus· 3 days agoOn May 8, 2024, Maximus Inc (MMS, Financial) released its 8-K filing, announcing financial results for the second quarter of fiscal year 2024. The company reported significant growth, with revenue ...